• +353-1-415-1241(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)

PRODUCT FILTERS

REGION

6
1

COUNTRY

1

CATEGORIES

  • 5
  • 3
  • 2
  • 1

PRICE

1
3
4
7

PUBLISHED

0
0
2
7

PRODUCT TYPE

7

Search "Emerging Opportunities in Biosimilar and Biobetter Drugs Markets" returned 7 results.

PRODUCT TITLE
Biosimilars: Current Situation & Future Prospects, Worldwide Biosimilars: Current Situation & Future Prospects, Worldwide - Product Thumbnail Image

Biosimilars: Current Situation & Future Prospects, Worldwide

The engine of the biosimilar sector is the same as with small molecule drugs, patent expiry On this basis, prospects for biosimilars look good, with the vast majority of leading originator brands in...

March 2012

Biobetters in Key Markets - Opportunities for Biotechnology Companies to Sustain Innovation with Low Risk and High Value Offerings

GBI Research, the leading business intelligence provider, has released its latest research on, “Biobetters in Key Markets - Opportunities for Biotechnology Companies to Sustain Innovation with Low Risk...

July 2012
FROM
Biosimilars and Biobetters: Positioning for a New Market Biosimilars and Biobetters: Positioning for a New Market - Product Thumbnail Image

Biosimilars and Biobetters: Positioning for a New Market

As regulatory frameworks for biosimilars development begin to take shape worldwide, there are growing opportunities for generics companies to enter the biologics market, a segment which is uniquely...

July 2009
Generics/Biosimilars Collection Generics/Biosimilars Collection - Product Thumbnail Image

Generics/Biosimilars Collection

Dossier Report Collections The authors are pleased to showcase Report Collections, focused on areas of critical importance to Pharma's success, present and future These Collections deliver expert views,...

November 2013
FROM

Fc Protein and Glycoengineered Antibodies Market, 2013 - 2023

Engineered antibodies are antibody based therapeutics, which are gaining increasing attention from both large and small pharmaceutical companies Developed through introduction of modifications in monoclonal...

September 2013
FROM
South Korea: Generics and Biosimilars Overview South Korea: Generics and Biosimilars Overview - Product Thumbnail Image

South Korea: Generics and Biosimilars Overview

Introduction There is growth potential in the South Korean generics market, driven by high out-of-pocket costs, an aging population and increasing chronic disease. However, there are also numerous...

August 2011
FROM
Biosimilars Biosimilars - Product Thumbnail Image

Biosimilars

In an environment where resources are scarce and patents are fast expiring, effective product planning is paramount to ensuring the success of your organisation Biologic drugs - noted as some of the...

March 2010
FROM
Loading Indicator